Pertuzumab: Development Beyond Breast Cancer | Anticancer Research
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism | Breast Cancer Research | Full Text
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer | Journal for ImmunoTherapy of Cancer | Full Text
Pertuzumab: new hope for patients with HER2-positive breast cancer - ScienceDirect
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions | SpringerLink
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes - ScienceDirect
Figure 1 | Recent Developments in HER2-Directed Therapy in Breast Cancer | SpringerLink
Treatment of Metastatic Breast Cancer - ppt download
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer. - Abstract - Europe PMC
Pertuzumab in human epidermal growth-factor receptor 2-positive breast | IJWH
Adj Therapy in Higher-Risk EBC - HER2+ EBC: Evolution - Text Module - HER2 EBC Treatment Landscape - Oncology - Clinical Care Options
Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer
The potential mode of action of trastuzumab and pertuzumab. (A) Five... | Download Scientific Diagram
Mode action of current ErbB2 inhibitors. Trastuzumab, pertuzumab, and... | Download Scientific Diagram
Use of Pertuzumab for the Treatment of HER2-Positive Metastatic Breast Cancer | Semantic Scholar
Mode action of current ErbB2 inhibitors. Trastuzumab, pertuzumab, and... | Download Scientific Diagram
How PERJETA® (pertuzumab) works for HER2+ Breast Cancer | HCP
Pertuzumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar | SpringerLink
SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy
Pertuzumab - Wikipedia
Pertuzumab in the treatment of HER2-positive breast cancer: an evidenc | CE
Precision medicine and personalized breast cancer: combination pertuzu | PGPM